Curium to launch $1.07 billion, €300 million term loans on Tuesday

By Sara Rosenberg

New York, July 24 – Curium BidCo Sarl will hold a lender call at 11 a.m. ET on Tuesday to launch a $1.066 billion term loan B due July 2029 and a €300 million term loan B due July 2029, according to a market source.

JPMorgan Chase Bank is the sole physical bookrunner on the U.S. term loan, and Deutsche Bank Securities Inc. is the sole physical bookrunner on the euro term loan. JPMorgan is the administrative agent.

Price talk on the U.S. term loan is SOFR plus 475 basis points with a 25 bps step-down at 3.5x senior secured net leverage, a 0% floor and an original issue discount of 98.5, and talk on the euro term loan is Euribor plus 475 bps with 25 bps step-downs at 3.5x and 3x senior secured net leverage, a 0% floor and a discount of 98.5, the source said.

Amortization on the U.S. term loan is 1% per annum, and the euro term loan has no amortization.

The term loans have 101 soft call protection for six months.

Commitments are due at 5 p.m. ET on Aug. 2 for the U.S. term loan and at noon ET on Aug. 2 for the euro term loan, the source added.

Proceeds will be used to amend and extend an existing $478 million term loan due July 2026, an existing $590 million term loan due December 2027 and an existing €300 million term loan due July 2026, and to pay transaction fees and expenses.

Curium is a nuclear medicine company with headquarters in London and Paris.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.